How are IOVA collar max profit and max loss calculated?

Max profit roughly equals short-call strike minus cost basis plus net premium; max loss roughly equals cost basis minus long-put strike minus net premium. Breakeven shifts by the net premium. For the IOVA collar priced from the August 14, 2026 end-of-day chain at a 30-day expiry (ATM IV 88.27%), the computed maximum profit is -$2.00 per contract and the computed maximum loss is -$52.00 per contract. Live intraday quotes will differ as the chain moves through the trading session.

What is the breakeven for a IOVA collar?

The breakeven for the IOVA collar priced on this page is no defined breakeven on the modeled curve at expiration, derived from the August 14, 2026 end-of-day chain's premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The IOVA market-implied 1-standard-deviation expected move in the same options snapshot is approximately 25.31%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.

How does current IOVA implied volatility affect this collar?

IOVA ATM IV is at 88.27% with IV rank near 16.12%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.

IOVA Collar Strategy

IOVA (Iovance Biotherapeutics, Inc.), in the Healthcare sector, (Biotechnology industry), listed on NASDAQ.

Iovance Biotherapeutics, Inc., a biotechnology firm currently in the clinical development stage, is committed to discovering and bringing to market cancer immunotherapy solutions. Its core mission involves leveraging the patient's own immune system to effectively combat and eradicate cancerous cells. The company is presently conducting six Phase 2 clinical trials. These include study C-144-01, evaluating its primary experimental compound, lifileucel, for individuals with advanced melanoma. Another trial, C-145-04, is assessing lifileucel's potential for treating cervical cancer that is recurrent, metastatic, or persistent. Additionally, investigational product LN-145 is undergoing evaluation in trial C-145-03 for recurrent and/or metastatic head and neck squamous cell carcinoma.

IOVA (Iovance Biotherapeutics, Inc.) trades in the Healthcare sector, specifically Biotechnology, with a market capitalization of approximately $3.01B, a beta of 0.70 versus the broader market, a 52-week range of 1.76-6.92, average daily share volume of 15.9M, a public-listing history dating back to 2010, approximately 975 full-time employees. These structural characteristics shape how IOVA stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.

A beta of 0.70 places IOVA roughly in line with broader market moves, so the strategy payoff and realized volatility track the index-equivalent baseline.

What is a collar on IOVA?

A collar pairs long stock with a protective out-of-the-money put financed by a short out-of-the-money call, capping both tails of the position around the current spot.

IOVA snapshot

As of August 14, 2026, spot at $6.88, ATM IV 88.27%, IV rank 16.12%, expected move 25.31%. The collar on IOVA below is built from the August 14, 2026 end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 28-day expiry.

Why this collar structure on IOVA specifically: IV regime affects collar pricing on both sides; compressed IOVA IV at 88.27% typically pushes the short call premium to roughly offset the long put cost, with a market-implied 1-standard-deviation move of approximately 25.31% (roughly $1.74 on the underlying). The 28-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated IOVA expiries trade a higher absolute premium for lower per-day decay. Position sizing on IOVA should anchor to the underlying notional of $6.88 per share and to the trader's directional view on IOVA stock.

IOVA collar setup

The IOVA collar below is built from the August 14, 2026 end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With IOVA at $6.88 on that close, the first option leg uses a $7.00 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed IOVA chain at a 28-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 IOVA shares for the stock leg in covered calls and collars).

Action	Type	Strike / Basis	Premium (est)
Buy 100 shares	Stock	$6.88	long
Sell 1	Call	$7.00	$0.50
Buy 1	Put	$6.50	$0.64

IOVA collar risk and reward

Net Premium / Debit: -$702.00
Max Profit (per contract): -$2.00
Max Loss (per contract): -$52.00
Breakeven(s): None on modeled curve
Risk / Reward Ratio: -0.038

Max profit roughly equals short-call strike minus cost basis plus net premium; max loss roughly equals cost basis minus long-put strike minus net premium. Breakeven shifts by the net premium.

IOVA collar payoff curve

Modeled P&L at expiration across a range of underlying prices for the collar on IOVA. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.

P&L at expiration across the modeled underlying-price range. Green shading marks profitable regions, red shading marks loss regions. Dotted purple verticals mark breakevens; the solid dark vertical marks current spot.

Underlying Price	% From Spot	P&L at Expiration
$0.01	-99.9%	-$52.00
$1.53	-77.8%	-$52.00
$3.05	-55.7%	-$52.00
$4.57	-33.6%	-$52.00
$6.09	-11.5%	-$52.00
$7.61	+10.6%	-$2.00
$9.13	+32.7%	-$2.00
$10.65	+54.8%	-$2.00
$12.17	+76.9%	-$2.00
$13.69	+99.0%	-$2.00

When traders use collar on IOVA

Collars on IOVA hedge an existing long IOVA stock position; the long put sets a floor while the short call finances it, often run as a near-zero-cost hedge during expected volatility windows.

IOVA thesis for this collar

The market-implied 1-standard-deviation range for IOVA extends from approximately $5.14 on the downside to $8.62 on the upside. A IOVA collar hedges an existing long IOVA position with a protective put while financing the put cost via a short call; when the premiums roughly offset, the collar acts as a near-zero-cost insurance band around the current spot. Current IOVA IV rank near 16.12% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on IOVA at 88.27%. As a Healthcare name, IOVA options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to IOVA-specific events.

IOVA collar positions are structurally neutral (protective); the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. IOVA positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move IOVA alongside the broader basket even when IOVA-specific fundamentals are unchanged. Always rebuild the position from current IOVA chain quotes before placing a trade.

Frequently asked questions

What is a collar on IOVA?: A collar on IOVA is the collar strategy applied to IOVA (stock). The strategy is structurally neutral (protective): A collar pairs long stock with a protective out-of-the-money put financed by a short out-of-the-money call, capping both tails of the position around the current spot. With IOVA stock at $6.88 on the August 14, 2026 close, the strikes shown on this page are snapped to the nearest listed IOVA chain strike and the premiums come straight from that session's bid/ask midpoint.
How are IOVA collar max profit and max loss calculated?: Max profit roughly equals short-call strike minus cost basis plus net premium; max loss roughly equals cost basis minus long-put strike minus net premium. Breakeven shifts by the net premium. For the IOVA collar priced from the August 14, 2026 end-of-day chain at a 30-day expiry (ATM IV 88.27%), the computed maximum profit is -$2.00 per contract and the computed maximum loss is -$52.00 per contract. Live intraday quotes will differ as the chain moves through the trading session.
What is the breakeven for a IOVA collar?: The breakeven for the IOVA collar priced on this page is no defined breakeven on the modeled curve at expiration, derived from the August 14, 2026 end-of-day chain's premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The IOVA market-implied 1-standard-deviation expected move in the same options snapshot is approximately 25.31%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
When should you consider a collar on IOVA?: Collars on IOVA hedge an existing long IOVA stock position; the long put sets a floor while the short call finances it, often run as a near-zero-cost hedge during expected volatility windows.
How does current IOVA implied volatility affect this collar?: IOVA ATM IV is at 88.27% with IV rank near 16.12%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.